{"disease":{"id":"nonsegmental-vitiligo","name":"nonsegmental vitiligo"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06072183","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1571,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT05583526","title":"A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06113445","title":"A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":467,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06113471","title":"A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06804811","title":"A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT07108283","title":"A Study of Zasocitinib in Adults With Nonsegmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06548360","title":"A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT04818346","title":"A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT07437560","title":"Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hudson Biotech","has_results":false},{"nct_id":"NCT05750823","title":"A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Incyte Corporation","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}